DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,029 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $14,610 | -7.9% | 58,477 | -7.9% | 2.37% | -10.3% |
Q1 2024 | $15,858 | +11.1% | 63,503 | +3.0% | 2.64% | +2.9% |
Q4 2023 | $14,269 | -5.0% | 61,680 | +1.9% | 2.56% | -15.1% |
Q3 2023 | $15,015 | +4.5% | 60,520 | +1.1% | 3.02% | +4.7% |
Q2 2023 | $14,371 | -5.7% | 59,880 | -0.9% | 2.88% | -7.2% |
Q1 2023 | $15,232 | -12.8% | 60,435 | -8.1% | 3.11% | -18.1% |
Q4 2022 | $17,460 | -99.9% | 65,783 | +0.5% | 3.79% | -5.0% |
Q3 2022 | $16,905,000 | -0.4% | 65,450 | -2.2% | 3.99% | +4.3% |
Q2 2022 | $16,973,000 | -14.4% | 66,948 | -0.9% | 3.83% | +0.9% |
Q1 2022 | $19,819,000 | -15.8% | 67,565 | -5.5% | 3.79% | -10.5% |
Q4 2021 | $23,532,000 | +0.9% | 71,524 | -6.6% | 4.24% | -4.6% |
Q3 2021 | $23,320,000 | +14.5% | 76,599 | +0.9% | 4.44% | +9.7% |
Q2 2021 | $20,374,000 | +19.5% | 75,920 | +0.2% | 4.05% | +7.5% |
Q1 2021 | $17,052,000 | +3.4% | 75,760 | +2.0% | 3.77% | -2.6% |
Q4 2020 | $16,497,000 | +2.7% | 74,264 | -0.4% | 3.87% | -11.6% |
Q3 2020 | $16,060,000 | +25.0% | 74,583 | +2.6% | 4.38% | +12.2% |
Q2 2020 | $12,852,000 | +26.5% | 72,679 | -1.0% | 3.90% | +3.3% |
Q1 2020 | $10,158,000 | -3.2% | 73,390 | +7.3% | 3.78% | +17.5% |
Q4 2019 | $10,494,000 | +8.4% | 68,376 | +2.0% | 3.22% | +3.2% |
Q3 2019 | $9,679,000 | +2.2% | 67,015 | +1.2% | 3.12% | +2.3% |
Q2 2019 | $9,468,000 | +7.7% | 66,247 | -0.5% | 3.05% | +6.1% |
Q1 2019 | $8,791,000 | +27.9% | 66,591 | -0.1% | 2.87% | +15.2% |
Q4 2018 | $6,873,000 | -5.5% | 66,651 | -0.4% | 2.49% | +17.4% |
Q3 2018 | $7,274,000 | +11.4% | 66,944 | +1.2% | 2.12% | +8.9% |
Q2 2018 | $6,530,000 | -4.8% | 66,173 | -5.6% | 1.95% | +9.4% |
Q1 2018 | $6,862,000 | +0.6% | 70,083 | -4.7% | 1.78% | +14.9% |
Q4 2017 | $6,824,000 | +11.6% | 73,514 | +3.1% | 1.55% | +7.9% |
Q3 2017 | $6,115,000 | -6.5% | 71,284 | -8.0% | 1.44% | -13.0% |
Q2 2017 | $6,539,000 | -7.7% | 77,490 | -6.4% | 1.65% | -7.9% |
Q1 2017 | $7,084,000 | – | 82,821 | – | 1.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |